0001567619-22-007042.txt : 20220316 0001567619-22-007042.hdr.sgml : 20220316 20220316154754 ACCESSION NUMBER: 0001567619-22-007042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kiraly Thomas E CENTRAL INDEX KEY: 0001623986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 22744759 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2022-03-15 0 0000722723 HANGER, INC. HNGR 0001623986 Kiraly Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 EVP & Chief Financial Officer Common Stock 2022-03-15 4 S 0 8750 19.1555 D 254854 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 31389 31389 D The sale by Mr. Kiraly was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Mr. Kiraly entered into this trading plan on November 15, 2021, and up to 26,250 additional shares could be sold through periodic quarterly sales that may occur under this plan through the end of 2022 if the conditions of the plan are met. These shares were sold at a range of sale prices from $18.86 to $19.47. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Stock options were granted under the Company's Special Equity Plan and vested 1/3 on each of May 19, 2018, 2019 and 2020. Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Kiraly 2022-03-16